{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-07",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "62332-467",
      "generic_name": "Tavaborole",
      "labeler_name": "Alembic Pharmaceuticals Inc.",
      "brand_name": "Tavaborole",
      "active_ingredients": [
        {
          "name": "TAVABOROLE",
          "strength": "43.5 mg/mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "62332-467-04",
          "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-04)  / 4 mL in 1 BOTTLE, DROPPER",
          "marketing_start_date": "20201023",
          "sample": false
        },
        {
          "package_ndc": "62332-467-10",
          "description": "1 BOTTLE, DROPPER in 1 CARTON (62332-467-10)  / 10 mL in 1 BOTTLE, DROPPER",
          "marketing_start_date": "20201023",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Alembic Pharmaceuticals Inc."
        ],
        "rxcui": [
          "1543177"
        ],
        "spl_set_id": [
          "22a6617b-d4b1-405e-901a-0b39a7b2837d"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000191279",
          "N0000000150",
          "M0002832"
        ],
        "pharm_class_epc": [
          "Oxaborole Antifungal [EPC]"
        ],
        "pharm_class_moa": [
          "Protein Synthesis Inhibitors [MoA]"
        ],
        "pharm_class_cs": [
          "Boron Compounds [CS]"
        ],
        "unii": [
          "K124A4EUQ3"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "SOLUTION",
      "spl_id": "d35e58d2-869d-40bf-a00e-296a9d3bb659",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "TOPICAL"
      ],
      "marketing_start_date": "20201023",
      "product_id": "62332-467_d35e58d2-869d-40bf-a00e-296a9d3bb659",
      "application_number": "ANDA212188",
      "brand_name_base": "Tavaborole",
      "pharm_class": [
        "Boron Compounds [CS]",
        "Oxaborole Antifungal [EPC]",
        "Protein Synthesis Inhibitors [MoA]"
      ]
    }
  ]
}